ATAGI pre-submission advice for industry sponsors wishing to make a PBAC submission

Cost recovery arrangements commenced on 1 July 2020 for Australian Technical Advisory Group on Immunisation (ATAGI) evaluation that supports Pharmaceutical Benefits Advisory Committee (PBAC) consideration of vaccines for the National Immunisation Program (NIP).

Cover image

Industry sponsors of vaccines seeking listing on the National Immunisation Program (NIP) Schedule are required to obtain advice from the Australian Technical Advisory Group on Immunisation (ATAGI) prior to providing a submission to the Pharmaceutical Benefits Advisory Committee (PBAC).

For more information refer to the ATAGI guidelines, procedures and templates on this page. 

Information for sponsors

This document provides procedural guidance to sponsors and contains the dates for each step of the ATAGI advice process for the scheduled meeting cycles annually in April, August and December.

Guidelines

Guidelines for preparing a request for advice from the Australian Technical Advisory Group on Immunisation (ATAGI) to support Pharmaceutical Benefits Advisory Committee (PBAC) consideration of vaccines.

Procedures

Procedures for Australian Technical Advisory Group on Immunisation (ATAGI) advice to the Pharmaceutical Benefits Advisory Committee (PBAC).

Template – pre-submission advice

Template for ATAGI pre-submission advice to PBAC - A guide for ATAGI members, ATAGI secretariat and evaluation groups.

Template – post-submission advice

Template for obtaining ATAGI advice, post-PBAC submission – A guide for PBAC evaluators, ESC and PBAC members.

About this resource

Publication date:
Publication type:
Guideline
Language:
English

Help us improve health.gov.au

If you would like a response please use the enquiries form instead.